Johansson L, Martínez F, Schröder R. "一种3-羟基-4-(羟甲基)-5-(羟甲基-d<SUB>2</SUB>)-2-甲基吡啶的合成方法" [P]. European Patent, EP 3807611 A1, 2018-04-19.
发明人何建平,朱建伟,周伟. "Method for the Synthesis of 5027-84-9
4-(Hydroxymethyl)-5-[hydroxy(~2~H_2_)methyl]-2-methylpyridin-3-ol
DTXSID50574084" [P]. 中国发明专利, 专利号 CN 114244547 B, 授权公告日 2025-10-19.
Roberts E F, Johnson M A, Park J H. "A Process for Preparing High-Purity 5027-84-9
4-(Hydroxymethyl)-5-[hydroxy(~2~H_2_)methyl]-2-methylpyridin-3-ol
DTXSID50574084" [P]. US Patent, US 11697382 B2, 2017-02-06.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of 3-羟基-4-(羟甲基)-5-(羟甲基-d<SUB>2</SUB>)-2-甲基吡啶 in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2014, 1770, (7), 6442-6449.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of 3-羟基-4-(羟甲基)-5-(羟甲基-d<SUB>2</SUB>)-2-甲基吡啶 as an Impurity". Talanta, 2012, 926, 3068-3098.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of 5027-84-9
4-(Hydroxymethyl)-5-[hydroxy(~2~H_2_)methyl]-2-methylpyridin-3-ol
DTXSID50574084 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2014, 1346, 6287-6293.